Engineered Drug Resistant γδ T Cells Kill Glioblastoma Cell Lines during a Chemotherapy Challenge: A Strategy for Combining Chemo- and Immunotherapy

Classical approaches to immunotherapy that show promise in some malignancies have generally been disappointing when applied to high-grade brain tumors such as glioblastoma multiforme (GBM). We recently showed that ex vivo expanded/activated γδ T cells recognize NKG2D ligands expressed on malignant g...

Descripción completa

Detalles Bibliográficos
Autores principales: Lamb, Lawrence S., Bowersock, Joscelyn, Dasgupta, Anindya, Gillespie, G. Yancey, Su, Yun, Johnson, Austin, Spencer, H. Trent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543433/
https://www.ncbi.nlm.nih.gov/pubmed/23326319
http://dx.doi.org/10.1371/journal.pone.0051805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543433/
https://www.ncbi.nlm.nih.gov/pubmed/23326319
http://dx.doi.org/10.1371/journal.pone.0051805

Ejemplares similares